Anthony Oliva, Ph.D., was awarded a total of $4 million through the Part the Cloud Challenge on Neuroinflammation.
There is a critical gap between laboratories where experimental drugs are developed and pharmacies where approved medications are dispensed. While the vast increase in our understanding of Alzheimer's has led to the identification of promising targets for new therapies, the process of developing and testing potential therapies is long and complex, taking years and substantial resources. There are few funding sources to support the earlier phase studies needed to test drug treatments in people. Many promising research ideas stall due to a lack of funding.
The Part the Cloud Global Research Program was created to address this gap. Founded in 2012 by philanthropist Mikey Hoag, the Part the Cloud movement advances research with the highest probability of slowing, stopping or ultimately curing Alzheimer’s disease. Part the Cloud partners with the Alzheimer’s Association to fund research projects that are specifically designed to accelerate the translation of findings from the laboratory into possible therapies — filling the gap in Alzheimer’s drug development by providing essential support for early-phase clinical studies. The Alzheimer's Association has awarded Part the Cloud research grants totaling $ since 2013.
Part the Cloud Challenges accelerate progress in high-potential areas of dementia science. Through the Part the Cloud Challenge on Neuroinflammation, four researchers were awarded $1 million each to harness an immune response to treat Alzheimer’s disease. Through the Part the Cloud to RESCUE (REverse, reStore, Cease and UndErstand) Brain Cell Degeneration in Alzheimer’s disease, six researchers received $1 million each to test innovative compounds to be used for interventions in the earliest stages of dementia.
The Part the Cloud + Bill Gates Partnership is propelling 19 high-risk, high-reward research projects aimed at uncovering underlying brain cell changes, improving timely diagnosis and developing new treatments for Alzheimer’s and all other dementia.
Part the Cloud also serves as a catalyst in helping researchers receive additional funding for their work. Projects funded by Part the Cloud have gone on to receive a total of $1 billion in follow-on funding from government entities, venture capital, industry and other funding sources. This follow-on funding has enabled studies to expand into clinical trials across the U.S., allows data sharing on a global scale and moves potential treatments through clinical trials faster.
Discovery Science
Early Detection
Treatment
Prevention
Step Up the Pace is a special initiative to increase philanthropic investment in four key dementia research outcomes areas: Discovery Science, Early Detection, Treatment and Prevention.
We use cookies to improve your experience on this website. Learn about options for managing your personal data in our Privacy Policy.